News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,151 Results
Type
Article (8094)
Company Profile (140)
Press Release (476820)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (166868)
Career Advice (304)
Deals (25761)
Drug Delivery (8)
Drug Development (52961)
Employer Resources (15)
FDA (9772)
Job Trends (8583)
News (238428)
Policy (17925)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (25)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33208)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (262)
Approvals (10382)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6966)
BIO (36)
BIOSECURE Act (2)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3632)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (477)
Cervical cancer (34)
Clinical research (47912)
Collaboration (1240)
Commercialization (3)
Compensation (1452)
Complete response letters (34)
COVID-19 (772)
CRISPR (63)
C-suite (740)
Cystic fibrosis (85)
Data (5633)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73730)
Editorial (1)
Employer branding (2)
Employer resources (15)
Events (87638)
Executive appointments (699)
FDA (12386)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (914)
Gene editing (125)
Generative AI (9)
Gene therapy (316)
GLP-1 (291)
Government (957)
Grass and pollen (2)
Guidances (281)
Healthcare (9338)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (105)
Immuno-oncology (56)
Indications (156)
Infectious disease (961)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (253)
Interviews (42)
IPO (12397)
IRA (2)
Job creations (1970)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Labor market (1)
Layoffs (59)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (250)
Machine learning (27)
Management (4)
Manufacturing (531)
Marketing (8)
MASH (118)
Medical device (8669)
Medtech (8810)
Mergers & acquisitions (14404)
Metabolic disorders (706)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1819)
NextGen: Class of 2026 (3156)
Non-profit (849)
Now hiring (5)
Obesity (224)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (503)
Peanut (31)
People (41243)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15484)
Phase 2 (21394)
Phase 3 (14414)
Pipeline (7265)
Policy (23)
Postmarket research (1574)
Preclinical (6545)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (570)
Real estate (3027)
Recruiting (7)
Regulatory (14833)
Reports (20)
Research institute (583)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (153)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2023)
Stomach cancer (3)
Supply chain (50)
Tariffs (2)
The Weekly (1)
Vaccines (326)
Venture capital (21)
Weight loss (74)
Women's health (78)
Date
Today (49)
Last 7 days (421)
Last 30 days (1626)
Last 365 days (19086)
2026 (12133)
2025 (19274)
2024 (23007)
2023 (26557)
2022 (34635)
2021 (37207)
2020 (33517)
2019 (23283)
2018 (17528)
2017 (18802)
2016 (17950)
2015 (24310)
2014 (21698)
2013 (18153)
2012 (20235)
2011 (20478)
2010 (20367)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17944)
Australia (2100)
California (11921)
Canada (3128)
China (518)
Colorado (482)
Connecticut (408)
Delaware (209)
Europe (24794)
Florida (1783)
Georgia (376)
Hawaii (3)
Idaho (46)
Illinois (696)
India (48)
Indiana (315)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1199)
Massachusetts (7837)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2616)
New Mexico (12)
New York (2814)
North Carolina (1269)
North Dakota (4)
Northern California (5966)
Ohio (276)
Oklahoma (14)
Oregon (19)
Pennsylvania (2246)
Puerto Rico (20)
Rhode Island (30)
South America (408)
South Carolina (76)
South Dakota (1)
Southern California (4948)
Tennessee (119)
Texas (1930)
United States (38741)
Utah (358)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (923)
West Virginia (1)
Wisconsin (73)
485,151 Results for "alumis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements
August 14, 2026
·
11 min read
Press Releases
Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
May 14, 2026
·
10 min read
Press Releases
Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements
March 20, 2026
·
11 min read
Press Releases
Alumis to Present at the Leerink Partners Global Healthcare Conference
March 2, 2026
·
1 min read
Immunology and inflammation
AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases
Presentations at the 2026 meeting of the American Academy of Dermatology not only demonstrate the therapeutic potential of next-generation skin drugs but also shed light on how they might fare on the market.
March 31, 2026
·
4 min read
·
Tristan Manalac
Press Releases
Alumis to Participate in Upcoming February 2026 Investor Conferences
February 5, 2026
·
1 min read
Press Releases
Alumis Announces Proposed Public Offering of Common Stock
January 7, 2026
·
3 min read
Press Releases
Alumis Announces Pricing of Upsized Public Offering of Common Stock
January 8, 2026
·
3 min read
Mergers & acquisitions
Acelyrin Rejects Concentra’s Buyout Offer in Favor of Alumis Merger
Acelyrin and Alumis plan to close their merger in the second quarter of 2025, pending clearances and shareholder approval.
March 5, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Major Shareholder Opposes Acelyrin’s Merger With Alumis, Prefers Wind-Down
It’s been a fraught road for the proposed merger between Acelyrin and Alumis, with Tang Capital’s Concentra Biosciences in February threatening to upend the deal with a proposed $3-per-share acquisition of Acelyrin.
April 30, 2025
·
2 min read
·
Tristan Manalac
1 of 48,516
Next
